YM Biosciences Inc has raised $15 million with the floatation of 3.75 million shares on the Toronto Stock Exchange and the Alternative Investment Market of the London Stock Exchange. The Mississauga-based YM will use the proceeds to expand and accelerate its product pipeline and commercial focus. The firm was formed to acquire the rights to develop drug products from a variety of research sources, with a focus on oncology. It has four products in clinical development, a fifth approved for trials and may acquire a sixth....